Monotherapy with AB680 or anti-PD-1 Ab partially slowed tumor progression, while combination therapy significantly increased the inhibitory effect on tumor growth (Fig. 1g, h) with no influence on mouse weight (Supplementary Fig. 1b). The gene discussed is PDCD1; the disease is neoplasm.